The Cooper Companies, Inc. $COO Shares Acquired by AIA Group Ltd

AIA Group Ltd boosted its position in The Cooper Companies, Inc. (NASDAQ:COO) by 53.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 37,278 shares of the medical device company’s stock after buying an additional 13,052 shares during the quarter. AIA Group Ltd’s holdings in Cooper Companies were worth $2,665,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Wellington Management Group LLP raised its stake in Cooper Companies by 332.9% during the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after acquiring an additional 4,756,178 shares during the period. Generation Investment Management LLP bought a new position in Cooper Companies in the fourth quarter worth about $233,539,000. Diamond Hill Capital Management Inc. boosted its stake in Cooper Companies by 479.6% in the fourth quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock valued at $269,471,000 after acquiring an additional 2,720,594 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in Cooper Companies by 58.8% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock valued at $494,123,000 after acquiring an additional 2,231,568 shares during the period. Finally, Franklin Resources Inc. grew its holdings in shares of Cooper Companies by 108.2% during the fourth quarter. Franklin Resources Inc. now owns 4,022,033 shares of the medical device company’s stock valued at $329,646,000 after purchasing an additional 2,089,763 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the company. Robert W. Baird dropped their price target on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a research report on Friday, June 5th. Wells Fargo & Company restated a “sell” rating and set a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. Stifel Nicolaus lowered their price objective on Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Friday, June 5th. Needham & Company LLC dropped their target price on Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. Finally, Piper Sandler set a $86.00 target price on Cooper Companies and gave the company an “overweight” rating in a research note on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, Cooper Companies currently has an average rating of “Hold” and an average price target of $81.85.

Cooper Companies Stock Performance

Shares of NASDAQ COO opened at $71.71 on Monday. The Cooper Companies, Inc. has a 12-month low of $58.89 and a 12-month high of $89.83. The company has a market cap of $13.99 billion, a PE ratio of 60.77, a P/E/G ratio of 1.87 and a beta of 0.84. The stock has a 50 day simple moving average of $66.24 and a 200-day simple moving average of $72.52. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. During the same period last year, the firm earned $0.96 EPS. The firm’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, equities research analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.